UroGen Pharma Ltd (URGN): Significant Improvements, Worth Being Considered
UroGen Pharma Ltd (NASDAQ:URGN) concluded the trading at $11.01 on Friday, January 31 with a fall of -3.00% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $11.35 and 5Y monthly beta